1887

Access Microbiology open research platform logo

Volume 6, Issue 1

Nephrogenic diabetes insipidus in a geriatric patient affected by SARS-CoV-2: complexity of a diagnosis, complexity of a virus Open Access

Abstract

Coronavirus disease 2019 (COVID-19) has an important impact on the kidney through direct and indirect damage mechanisms. Most previous studies have highlighted lesions caused by this virus in the early segments of the nephron. However, due to the antigenic characteristics of the virus, with almost ubiquitous receptors, and the molecular release it triggers, the distal segments of the nephron could also be affected.

A 71 year-old-man with respiratory failure while suffering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia presented with typical symptoms of diabetes insipidus after ~20 days of hospitalization. The water deprivation test led to the diagnosis of nephrogenic diabetes insipidus. The aetiological study was complex, in particular because of the patient’s previous lithium therapy.

The sequence of pathognomonic events typical of diabetes insipidus associated with anamnestic, clinical and laboratory evidence strongly supported the diagnosis of nephrogenic diabetes insipidus due to SARS-CoV-2 rather than other aetiologies.

The collecting duct could represent a target for SARS-CoV-2 infection, directly or indirectly, as a result of lesions of upstream portions of the nephron, which would cascade into the distal segment. Other molecules, besides angiotensin 2 converting enzyme, might be involved in facilitating the viral aggression. The complexity of the geriatric patient shows the importance of a comprehensive approach that integrates careful monitoring of clinical signs and symptoms and laboratory and instrumental tests. This is especially important in the context of SARS-CoV-2 infection and in the management of its unexpected complications.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): angiotensin 2 converting enzyme , inflammation , nephrogenic diabetes insipidus , polyuria , severe acute respiratory syndrome coronavirus 2 , transmembrane serine protease type 2 and urinary osmolarity
© 2024 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000598.v4
2024-01-31
2024-05-20
Loading full text...

Full text loading...

/deliver/fulltext/acmi/6/1/acmi000598.v4.html?itemId=/content/journal/acmi/10.1099/acmi.0.000598.v4&mimeType=html&fmt=ahah

References

  1. WHO Coronavirus (COVID-19) dashboard. n.d https://covid19.who.int/ accessed 22 November 2023
  2. Istituto Superiore di Sanità. n.d https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_5-gennaio-2022.pdf accessed 22 November 2023
  3. Ferrarese C, Silani V, Priori A, Galimberti S, Agostoni E et al. An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID). Neurol Sci 2020; 41:1355–1359 [View Article] [PubMed]
     [Google Scholar]
  4. Azevedo RB, Botelho BG, Hollanda JVG de, Ferreira LVL, Junqueira de Andrade LZ et al. Covid-19 and the cardiovascular system: a comprehensive review. J Hum Hypertens 2021; 35:4–11 [View Article] [PubMed]
     [Google Scholar]
  5. Tian D, Ye Q. Hepatic complications of COVID-19 and its treatment. J Med Virol 2020; 92:1818–1824 [View Article] [PubMed]
     [Google Scholar]
  6. Huang C, Wang Y, Li X, Ren L, Zhao J et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497–506 [View Article] [PubMed]
     [Google Scholar]
  7. Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science 2020; 368:473–474 [View Article] [PubMed]
     [Google Scholar]
  8. Pan XW, Xu D, Zhang H, Zhou W, Wang LH et al. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med 2020; 46:1114–1116 [View Article] [PubMed]
     [Google Scholar]
  9. Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E et al. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med 2020; 46:1339–1348 [View Article] [PubMed]
     [Google Scholar]
  10. Coppola S, Cenci S, Cozzolino M, Chiumello D. Sevoflurane sedation and nephrogenic diabetes insipidus in patients affected with severe acute respiratory syndrome coronavirus 2. Eur J Anaesthesiol 2021; 38:438–441 [View Article] [PubMed]
     [Google Scholar]
  11. Farkash EA, Wilson AM, Jentzen JM. Ultrastructural evidence for direct renal infection with SARS-CoV-2. J Am Soc Nephrol 2020; 31:1683–1687 [View Article] [PubMed]
     [Google Scholar]
  12. Su H, Yang M, Wan C, Yi L-X, Tang F et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 2020; 98:219–227 [View Article] [PubMed]
     [Google Scholar]
  13. Di Iorgi N, Napoli F, Allegri AEM, Olivieri I, Bertelli E et al. Diabetes insipidus--diagnosis and management. Horm Res Paediatr 2012; 77:69–84 [View Article] [PubMed]
     [Google Scholar]
  14. https://www.merckmanuals.com/medical-calculators/WaterDeficit-it.htm
  15. World Health Organization What we know about long-term effects of COVID-19. The latest on the COVID-19 global situation & long-term sequelae. n.d https://www.who.int/docs/default-source/coronaviruse/risk-comms-updates/update54_clinical_long_term_effects.pdf?sfvrsn=3e63eee5_8 accessed 18 May 2021
  16. Sheikh AB, Javed N, Sheikh AAE, Upadhyay S, Shekhar R. Diabetes insipidus and concomitant myocarditis: a late sequelae of COVID-19 infection. J Investig Med High Impact Case Rep 2021; 9:2324709621999954 [View Article] [PubMed]
     [Google Scholar]
  17. Ren X, Wang S, Chen X, Wei X, Li G et al. Multiple expression assessments of ACE2 and TMPRSS2 SARS-CoV-2 entry molecules in the urinary tract and their associations with clinical manifestations of COVID-19. Infect Drug Resist 2020; 13:3977–3990 [View Article] [PubMed]
     [Google Scholar]
  18. Wang K, Chen W, Zhang Z, Deng Y, Lian J-Q et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther 2020; 5:283 [View Article] [PubMed]
     [Google Scholar]
  19. Song J, Zhu J, Chen W, Zhu G, Wang W et al. Expression profiles revealed potential kidney injury caused by SARS-CoV-2: a systematic analysis of ACE2 and clinical lessons learned from this discovery. Aging 2021; 13:10821–10832 [View Article]
     [Google Scholar]
  20. Nadim MK, Forni LG, Mehta RL, Connor MJ Jr, Liu KD et al. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) workgroup. Nat Rev Nephrol 2020; 16:747–764 [View Article] [PubMed]
     [Google Scholar]
  21. Bernardi S, Burns WC, Toffoli B, Pickering R, Sakoda M et al. Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7). Clin Sci 2012; 123:29–37 [View Article] [PubMed]
     [Google Scholar]
  22. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA et al. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med 2020; 382:1653–1659 [View Article] [PubMed]
     [Google Scholar]
  23. Puelles VG, Lütgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med 2020; 383:590–592 [View Article] [PubMed]
     [Google Scholar]
  24. Rej S, Pira S, Marshe V, Do A, Elie D et al. Molecular mechanisms in lithium-associated renal disease: a systematic review. Int Urol Nephrol 2016; 48:1843–1853 [View Article] [PubMed]
     [Google Scholar]
  25. Shakaroun D, Nasser H, Munie S, Soman S. Nephrogenic diabetes insipidus after esophagectomy in a patient with remote history of lithium treatment: a case report. Int J Surg Case Rep 2019; 57:71–73 [View Article] [PubMed]
     [Google Scholar]
  26. Stone KA. Lithium-induced nephrogenic diabetes insipidus. J Am Board Fam Pract 1999; 12:43–47 [View Article] [PubMed]
     [Google Scholar]
  27. Dupuis C, Robert A, Gerard L, Morelle J, Laterre P-F et al. Nephrogenic diabetes insipidus following an Off-label administration of sevoflurane for prolonged sedation in a COVID-19 patient and possible influence on aquaporin-2 renal expression. Case Rep Anesthesiol 2022; 2022:3312306 [View Article] [PubMed]
     [Google Scholar]
  28. Goo YJ, Song SH, Kwon OI, Kim M, Suh SH et al. Venous thromboembolism and severe hypernatremia in a patient with lithium-induced nephrogenic diabetes insipidus and acute kidney injury: a case report. Ann Palliat Med 2022; 11:2756–2760 [View Article] [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/acmi/10.1099/acmi.0.000598.v4
Loading
Nephrogenic diabetes insipidus in a geriatric patient affected by SARS-CoV-2: complexity of a diagnosis, complexity of a virus
Access Microbiology 6, 000598.v4 (2024); https://doi.org/10.1099/acmi.0.000598.v4
/content/journal/acmi/10.1099/acmi.0.000598.v4
/content/journal/acmi/10.1099/acmi.0.000598.v4
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error